
Hau Van Phan
Examiner (ID: 8779, Phone: (571)272-6696 , Office: P/3618 )
| Most Active Art Unit | 3618 |
| Art Unit(s) | 3618, 3613, 3615, 3619, 3611 |
| Total Applications | 2398 |
| Issued Applications | 1830 |
| Pending Applications | 100 |
| Abandoned Applications | 497 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18443568
[patent_doc_number] => 11679119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Bortezomib compositions
[patent_app_type] => utility
[patent_app_number] => 17/934901
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20951
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934901 | Bortezomib compositions | Sep 22, 2022 | Issued |
Array
(
[id] => 18124763
[patent_doc_number] => 20230010375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => ANTI-VIRAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/947314
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947314 | ANTI-VIRAL COMPOSITION | Sep 18, 2022 | Pending |
Array
(
[id] => 18509923
[patent_doc_number] => 20230226009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => NEW COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE
[patent_app_type] => utility
[patent_app_number] => 17/940958
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940958
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940958 | Combination comprising N-acetyl-L-cysteine and its use | Sep 7, 2022 | Issued |
Array
(
[id] => 18179922
[patent_doc_number] => 20230040651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => METAL (HYDR)OXIDE COMPOSITE COMPRISING POORLY SOLUBLE DRUG, METHOD FOR MANUFACTURING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/890796
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 400
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890796 | Metal (hydr)oxide composite comprising poorly soluble drug, method for manufacturing same, and pharmaceutical composition comprising same | Aug 17, 2022 | Issued |
Array
(
[id] => 18683856
[patent_doc_number] => 11779566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => ST-246 (tecovirimat monohydrate) suspension formulations
[patent_app_type] => utility
[patent_app_number] => 17/864909
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 19065
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864909 | ST-246 (tecovirimat monohydrate) suspension formulations | Jul 13, 2022 | Issued |
Array
(
[id] => 18434447
[patent_doc_number] => 20230181741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => RIFAXIMIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/862491
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862491 | Rifaximin complexes | Jul 11, 2022 | Issued |
Array
(
[id] => 18412017
[patent_doc_number] => 11666544
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-06
[patent_title] => Compositions and methods for treating hypertension
[patent_app_type] => utility
[patent_app_number] => 17/857985
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12570
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857985 | Compositions and methods for treating hypertension | Jul 4, 2022 | Issued |
Array
(
[id] => 17928221
[patent_doc_number] => 20220323346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => DISSOLVABLE POLYMERIC EYE INSERTS WITH A BIODEGRADABLE POLYMER AND METHOD OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/808342
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808342 | Dissolvable polymeric eye inserts with a biodegradable polymer and method of using the same | Jun 22, 2022 | Issued |
Array
(
[id] => 19554920
[patent_doc_number] => 20240366712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => GRIFFITHSIN FOR USE IN A METHOD OF PREVENTING OR TREATING INFECTIONS WITH RESPIRATORY VIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/573294
[patent_app_country] => US
[patent_app_date] => 2022-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573294
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573294 | GRIFFITHSIN FOR USE IN A METHOD OF PREVENTING OR TREATING INFECTIONS WITH RESPIRATORY VIRUSES | Jun 21, 2022 | Abandoned |
Array
(
[id] => 17911465
[patent_doc_number] => 20220313860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Additive Compositions for Pigmented Disinfection and Methods Thereof
[patent_app_type] => utility
[patent_app_number] => 17/845074
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845074 | Additive compositions for pigmented disinfection and methods thereof | Jun 20, 2022 | Issued |
Array
(
[id] => 19216118
[patent_doc_number] => 20240180822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES
[patent_app_type] => utility
[patent_app_number] => 18/568694
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18568694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/568694 | NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES | Jun 13, 2022 | Pending |
Array
(
[id] => 18171758
[patent_doc_number] => 11571451
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-02-07
[patent_title] => Phytotherapeutic product for correction of symptom-complex of fibrocystic changes of mammary gland
[patent_app_type] => utility
[patent_app_number] => 17/839089
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3655
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839089 | Phytotherapeutic product for correction of symptom-complex of fibrocystic changes of mammary gland | Jun 12, 2022 | Issued |
Array
(
[id] => 18064370
[patent_doc_number] => 20220395457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/836588
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836588 | Dry powder formulations of epinephrine and associated methods | Jun 8, 2022 | Issued |
Array
(
[id] => 19297826
[patent_doc_number] => 20240226392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => PHOTOCURABLE DEVICES AND ADDITIVE MANUFACTURING METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/561058
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561058
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561058 | PHOTOCURABLE DEVICES AND ADDITIVE MANUFACTURING METHODS OF MAKING THE SAME | Jun 7, 2022 | Pending |
Array
(
[id] => 17865228
[patent_doc_number] => 20220287963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
[patent_app_type] => utility
[patent_app_number] => 17/831946
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831946 | Hydrocortisone acetate suppository formulation for treatment of disease | Jun 2, 2022 | Issued |
Array
(
[id] => 19331181
[patent_doc_number] => 20240245611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => HARD-SHELL CAPSULE WITH INFLUX PREVENTION OF GASTRIC FLUIDS
[patent_app_type] => utility
[patent_app_number] => 18/563327
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563327
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563327 | HARD-SHELL CAPSULE WITH INFLUX PREVENTION OF GASTRIC FLUIDS | May 22, 2022 | Pending |
Array
(
[id] => 19541610
[patent_doc_number] => 20240358646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => HARD SHELL CAPSULES WITH MODIFIED RELEASE COATING
[patent_app_type] => utility
[patent_app_number] => 18/563517
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563517
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563517 | HARD SHELL CAPSULES WITH MODIFIED RELEASE COATING | May 18, 2022 | Pending |
Array
(
[id] => 17836234
[patent_doc_number] => 20220273539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING AND REVERSING ASPECTS OF AGING
[patent_app_type] => utility
[patent_app_number] => 17/745190
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745190 | Compositions and methods for preventing and reversing aspects of aging | May 15, 2022 | Issued |
Array
(
[id] => 19359184
[patent_doc_number] => 20240261218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => BIODEGRADABLE MUCOADHESIVE PHARMACEUTICAL FORMULATIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/562374
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562374
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562374 | BIODEGRADABLE MUCOADHESIVE PHARMACEUTICAL FORMULATIONS AND METHODS THEREOF | May 12, 2022 | Pending |
Array
(
[id] => 18347427
[patent_doc_number] => 20230135537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => NEBULIZATION FORMULATIONS FOR DELIVERY TO LOWER RESPIRATORY TRACT
[patent_app_type] => utility
[patent_app_number] => 17/740790
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740790 | Nebulization formulations for delivery to lower respiratory tract | May 9, 2022 | Issued |